BridgeMD

Sign in

Rare Diseases clinical trials

Explore recruiting rare diseases clinical trials.

Recruiting rare diseases studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rare Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Development and delivery of personalized 3D-printed drugs to improve treatment adherence in children with rare diseases.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Open, randomized, IInd phase clinical study evaluating the safety and efficacy of rapamycin in the treatment of drug-resistant epilepsy in children with rare and ultra rare diseases of the central nervous system associated with the activation of the mTOR pathway : BraimTOR-NEURO

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Sleep structure in neuropathic pain patients, psychological factors, brain connectivity, and the effect of pregabalin on sleep and pain

Finland

Therapeutic use (Phase IV) EU CTIS Study details

An open randomized phase II clinical trial evaluating the safety and efficacy of rapamycin in the treatment of gliomas high-grade malignant gliomas in children as part of the establishment management of rare and ultra rare diseases of the central nervous system associated with mTOR pathway activation: BraimTOR- ONKO

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of the Efficacy of Valsartan in Slowing Down Aortic Root Dilatation in Children and Young Adults with Marfan-type Heritable Thoracic Aortic Diseases – Valsar-TAD, a randomised, double-blind, placebo-controlled multicentre trial

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase II, Multicenter Study to Assess Safety and Efficacy of Combination of Sargramostim with D-VCd Therapy (Daratumumab, Cyclophosphamide, Bortezomib, Dexamethasone) in Untreated Patients with Light Chain Amyloidosis

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Rare Diseases trials by city

Rare Diseases in Toronto Rare Diseases in Vancouver Rare Diseases in Montreal Rare Diseases in Calgary Rare Diseases in Edmonton Rare Diseases in Ottawa Rare Diseases in Winnipeg Rare Diseases in Quebec City Rare Diseases in Hamilton Rare Diseases in Kitchener Rare Diseases in London Rare Diseases in Halifax Rare Diseases in New York Rare Diseases in Los Angeles Rare Diseases in Chicago Rare Diseases in Houston